What Happens If You Don’t Have a Pancreas?

Losing your entire pancreas is survivable, but it changes your body in profound ways that require daily, lifelong management. Without this organ, you lose both insulin production and the digestive enzymes needed to break down food, meaning you become immediately dependent on injected insulin and swallowed enzyme capsules for every meal. The challenges go well beyond blood sugar control: people living without a pancreas face heightened risks of dangerous low blood sugar episodes, malnutrition, fatty liver disease, and bone loss, and their quality of life scores tend to run lower than those of the general population.

Blood Sugar Becomes Dangerously Unpredictable

The pancreas houses two critical hormone-producing cell types. Beta cells make insulin, which lowers blood sugar, and alpha cells make glucagon, which raises it. When the entire organ is removed in a procedure called a total pancreatectomy, both are gone. That creates a form of diabetes sometimes called type 3c diabetes or, more specifically, post-total-pancreatectomy diabetes, which is distinct from the more familiar type 1 and type 2 varieties.¹

What makes this form of diabetes particularly difficult is that you are not just missing insulin. You are also missing glucagon, amylin, and pancreatic polypeptide. Glucagon is your body’s main emergency brake against low blood sugar. When a healthy person’s glucose drops too far, alpha cells release glucagon to pull stored sugar from the liver. Without it, a dose of injected insulin that turns out to be slightly too large has no natural counterbalance.² Researchers describe this state as “brittle diabetes” because glucose levels swing wildly through the day and are extremely hard to stabilize with injected insulin alone.

The hypoglycemia risk is not just an inconvenience. People without a pancreas can experience blood sugar levels dropping below 30 mg/dL, a zone that can cause seizures, loss of consciousness, and even death, while simultaneously losing their ability to feel the warning signs. This condition, known as hypoglycemia unawareness, develops because the body’s normal alarm system relies partly on glucagon and adrenaline responses that become blunted over time.³ The combination of no glucagon, increased sensitivity to insulin at the tissue level, and unpredictable absorption of food (more on that below) means that managing blood sugar after total pancreatectomy is substantially harder than managing typical type 1 diabetes.

Digesting Food Requires Enzyme Capsules at Every Meal

The pancreas is also a digestive workhorse. Its exocrine tissue secretes enzymes, primarily lipase, protease, and amylase, that break down fats, proteins, and starches in the small intestine. Without these enzymes, food passes through largely undigested. The most obvious symptom is steatorrhea: pale, greasy, foul-smelling stools caused by fat passing straight through the gut. Cramping, bloating, and progressive weight loss follow closely behind.⁴

The treatment is pancreatic enzyme replacement therapy, or PERT, which consists of capsules containing porcine-derived enzymes taken with every meal and snack. Guidelines recommend starting at roughly 40,000 to 50,000 lipase units per meal and about half that with snacks.⁵ UK guidelines recommend a somewhat higher starting dose of 50,000 units per meal.⁶ The capsules need to be spread throughout the meal rather than swallowed all at once, so the enzymes mix properly with food as it enters the small intestine.

In practice, many people end up under-dosed. A systematic review found that about 40% of studies reported average doses below the recommended threshold. At those lower doses, diarrhea improved, but nutritional status did not. Only when doses reached guideline levels did both symptoms and nutrition improve.⁷ That distinction matters: feeling better in the bathroom is not the same as actually absorbing the nutrients your body needs.

Fat-Soluble Vitamins and Bone Health Take a Hit

When fat is not absorbed properly, the fat-soluble vitamins that ride along with it, vitamins A, D, E, and K, also go unabsorbed. In patients with chronic pancreatic disease, vitamin K deficiency has been found in roughly 63% and vitamin D deficiency in about 53%, with vitamins A and E less commonly but still significantly affected.⁸ The consequences are not abstract. Vitamin D deficiency weakens bones. Vitamin K deficiency impairs blood clotting. Vitamin A affects vision and immune function.

Bone loss is particularly common. The same research found reduced bone mineral density in over half of patients, with frank osteoporosis in about 10%, even among some patients whose exocrine function tested as adequate. Children undergoing total pancreatectomy with islet autotransplantation show similar vitamin D insufficiency rates, around a quarter at one year after surgery, with longer disease duration before surgery making deficiency more likely.⁹ These deficiencies persist even in patients taking enzyme replacement and vitamin supplements, suggesting that monitoring and dose adjustments need to be ongoing rather than one-and-done.

Fatty Liver Disease After Pancreas Removal

One of the less intuitive consequences of losing a pancreas is developing a fatty liver. You might expect that poor nutrient absorption would make fat accumulation unlikely, but the opposite often happens. A systematic review found that new fatty liver disease can develop within 12 months of pancreatectomy, with incidence rates reported as high as 75%.¹⁰

The mechanism appears to involve glucagon loss. Glucagon normally helps the liver process amino acids and regulate fat metabolism. Without it, amino acids build up in the blood, and the liver accumulates fat even as the patient’s overall body weight drops. A prospective study tracked patients for a year after pancreatic resection and found increased liver fat in the majority, with one individual showing an 80-percentage-point increase despite losing weight.¹¹ Other risk factors include malnutrition around the time of surgery, how much pancreatic tissue was removed, and female sex.¹² Whether this post-pancreatectomy fatty liver progresses to serious liver disease over many years is still being studied, but it adds yet another organ system to the list that needs monitoring after surgery.

Why a Pancreas Gets Removed

Total pancreatectomy is never a casual decision. Surgeons remove the entire pancreas when other options have been exhausted. The most common reasons include pancreatic cancer that requires wide surgical margins, precancerous growths like intraductal papillary mucinous neoplasms that involve the whole gland, and chronic pancreatitis that causes intractable pain and has not responded to more conservative surgery or medication. In some cases, the initial plan is to remove only part of the pancreas, but the surgeon finds during the operation that the disease extends too far.

When the operation is done for chronic pancreatitis, a technique called total pancreatectomy with islet autotransplantation (TPIAT) allows surgeons to salvage the patient’s own insulin-producing islet cells. The pancreas is removed, the islet cells are extracted in a lab, and then infused into the patient’s liver, where they can engraft and continue producing at least some insulin. A large multicenter study found that 20% of patients were completely insulin independent at one year after TPIAT, and the average hemoglobin A1c (a marker of long-term blood sugar control) was 7%, which is close to the target for most people with diabetes.¹³ Beyond blood sugar, the procedure dramatically reduced pain: daily abdominal pain dropped from 65% of patients before surgery to 23% after, and opioid use fell from 61% to 24%.

A meta-analysis pooling 17 studies found that TPIAT effectively relieved pain without increasing mortality or complication rates, though it noted high variation between studies in how insulin independence was defined and measured.¹⁴ TPIAT is not available for cancer patients, because the processing step could theoretically reintroduce cancer cells into the liver.

Technology That Helps Manage Blood Sugar

Standard insulin management after total pancreatectomy typically involves multiple daily injections or an insulin pump, guided by frequent finger-stick blood sugar checks or a continuous glucose monitor (CGM). CGM systems, which use a small sensor under the skin to track glucose levels every few minutes, reduce the burden of constant finger-pricking, though they have quirks in this patient population. For example, hydroxyurea, a medication sometimes given after islet autotransplantation, can cause CGM sensors to read falsely high, which could lead someone to under-dose their insulin.¹⁵

The most promising development is the closed-loop artificial pancreas, sometimes called an automated insulin delivery system. These devices link a CGM to an insulin pump via an algorithm that continuously adjusts doses without the patient needing to intervene. In patients recovering from pancreatic surgery, a fully closed-loop system nearly doubled the time spent in the target glucose range compared with standard care, reaching about 78% versus 41% time in range, without increasing hypoglycemia.¹⁶

Even more intriguing are bihormonal systems that deliver both insulin and glucagon, essentially replacing both missing hormones simultaneously. A randomized trial in patients after total pancreatectomy found that a bihormonal artificial pancreas kept patients in the normal glucose range about 78% of the time compared with roughly 57% on conventional insulin therapy, and essentially eliminated time spent in hypoglycemia.¹⁷ The dual-hormone approach seems especially helpful during daytime and exercise, when hypoglycemia risk spikes, while insulin-only closed-loop systems already handle nighttime control well.¹⁸ These systems are still largely in the research phase for this specific population, but they represent a real shift toward restoring some of the metabolic balance that the missing pancreas once maintained.

Immune System Consequences When the Spleen Goes Too

Total pancreatectomy often involves removing the spleen as well, because the two organs share a blood supply via the splenic artery. Losing your spleen is a separate medical event with its own consequences. The spleen produces proteins called opsonins that help your immune system fight encapsulated bacteria, the kind responsible for serious infections like pneumonia, meningitis, and bloodstream infections. Without it, your vulnerability to these infections rises significantly and remains elevated for life.¹⁹

People who have had their spleen removed need vaccinations against specific bacteria, including pneumococcus, meningococcus, and Haemophilus influenzae type b, ideally given before the surgery if it is planned. Many also carry a course of emergency antibiotics to take at the first sign of fever or infection, because what would be a manageable infection for someone with a spleen can escalate rapidly without one. This is yet another layer of lifelong vigilance added to the already substantial daily management after total pancreatectomy.

Gastrointestinal Rerouting and Dumping Syndrome

The physical removal of the pancreas also requires rearranging the plumbing of the digestive tract. The pancreas sits snugly against the duodenum (the first stretch of the small intestine), and removing it means the bile duct and the remaining stomach or duodenal stump need to be reconnected to the intestine. In procedures that also remove the head of the pancreas and duodenum, surgeons debate whether to preserve or resect the pylorus, the muscular valve at the stomach’s exit.

Removing the pylorus can lead to dumping syndrome, a condition where food rushes too quickly from the stomach into the small intestine. Symptoms include nausea, cramping, diarrhea, dizziness, and sweating after eating, and it can significantly affect quality of life and nutritional status. Preserving the pylorus generally avoids this, though it can sometimes lead to delayed gastric emptying, where the stomach takes too long to pass food along.²⁰ Either way, many people after total pancreatectomy find that their relationship with eating fundamentally changes: meals need to be smaller, more frequent, carefully timed with enzyme capsules and insulin, and sometimes accompanied by careful food choices to avoid triggering symptoms.

What Quality of Life Actually Looks Like

The honest picture is that people without a pancreas live with measurably reduced quality of life, but the gap is smaller than many expect. A nationwide Dutch cohort study found that total pancreatectomy patients reported slightly lower overall health scores compared to the general population, and these scores did not worsen further whether it had been less than three years or more than five years since surgery. Patients reported similar levels of diabetes-related distress as people with type 1 diabetes, and most were generally satisfied with their diabetes treatment.²¹

A Japanese study of long-term survivors found that nearly all patients (96%) could manage their diabetes independently, and quality-of-life scores were broadly comparable to the national population averages, including among elderly patients. The main drag on quality of life was persistent diarrhea, which affected about a third of patients and correlated with lower scores.²²

An Italian analysis of 94 long-term survivors told a slightly less optimistic story, finding that both physical and mental health scores were significantly lower than population norms. Younger patients, those with ongoing abdominal pain, and those with negative body image perceptions fared worst on the physical side, while diabetes burden and sexual satisfaction affected mental health scores.²³ The variation across studies likely reflects differences in why the pancreas was removed (cancer versus chronic pain versus precancerous growths), whether islet autotransplantation was performed, and how well enzyme and insulin therapy were optimized.

Qualitative research adds texture that numbers miss. Patients describe diabetes management as the most life-altering change, followed by the constant adjustments around food and physical weakness. Many describe a psychological journey that includes grief over their changed body, anxiety about blood sugar emergencies, and gradual adaptation over months to years. The support of family, friends, and a responsive healthcare team consistently emerges as the most important factor in coping.

The Financial Weight of Lifelong Treatment

Living without a pancreas requires medications and supplies that never stop. Insulin, enzyme capsules, CGM sensors, pump supplies, vitamin supplements, and regular blood work add up. A recent study focused specifically on enzyme replacement costs found that patients who had undergone a distal pancreatectomy (which removes less tissue than a total pancreatectomy and thus requires lower enzyme doses) paid roughly $4,700 out of pocket for PERT alone over five years, while those after a more extensive resection paid about $5,600.²⁴ For someone after total pancreatectomy who needs the highest enzyme doses, the costs are at the upper end. And those figures cover only enzymes, not insulin, monitoring supplies, or the frequent specialist visits that come with the territory.

Insurance coverage and subsidy programs can dramatically reduce out-of-pocket costs, but access varies widely. The financial pressure creates a real clinical problem: when enzyme capsules are expensive, patients sometimes ration them, which leads to malabsorption, which leads to vitamin deficiency and weight loss, which leads to more medical visits and costs. It is a cycle that clinicians managing these patients recognize and try to head off early.

Born Without a Pancreas

While most people who live without a pancreas lost it to surgery, an extremely rare congenital condition called pancreatic agenesis means some infants are born without one. These babies typically present with severe growth restriction and immediate neonatal diabetes. A study analyzing growth patterns in these infants found that they were profoundly small, with median birth weights at the 0.5th centile, far below what is expected even for premature babies.²⁵ Earlier delivery was associated with relatively higher growth centiles, suggesting that insulin deficiency in utero has an increasingly severe effect on growth as pregnancy progresses. Management from birth mirrors the post-surgical situation: lifelong insulin and enzyme replacement, along with careful nutritional support.

How the Pancreas-Diabetes Connection Was Discovered

The pivotal experiment happened in 1889, when Oskar Minkowski removed the entire pancreas from a dog to study fat digestion and inadvertently created the first animal model of diabetes. Minkowski had no intention of studying blood sugar. But when his lab assistant complained that the dog could not stop urinating, Minkowski tested the urine and found sugar levels above 10%, an unmistakable sign of severe diabetes.²⁶ That accidental discovery proved for the first time that the pancreas contained something essential for controlling blood sugar, and it set in motion the research that led to the isolation of insulin three decades later. In a very real sense, the question “what happens if you don’t have a pancreas” is the question that launched modern diabetes medicine.